Karissa Lowden
Kansas City,MO
Summary
Active Clinical Manager with over 5 years of experience managing staff members and services in a clinical setting. Compassionate and industrious with excellent interpersonal and organizational skills. Dedicated to adhering to quality standards for patients and staff. Talented at supervising, mentoring and preparing staff evaluations and administrative reports for 6 personnel.
Overview
5
5
years of professional experience
Work History
Clinical Operations Manager
University of Kansas Cancer Center
Westwood, KS
11.2021 - Current
- Manage and serve as primary contact for assigned clinical trial activities
- Develop, understand, and manage contractual and organizational expectations; nurture internal and external stakeholder relationships and needs
- Primary contact for all protocol clarifications and logistical project related concerns
- Assign, review, and train individual staff and multiple study teams
- Employ escalation and performance plans as needed
- Provide oversight and training to team members who are responsible for recruitment, obtaining informed consent, performing protocol required study procedures, maintaining essential documentation
- Communicated effectively with staff members, physicians and patients, employing active listening and interpersonal skills.
- Regularly evaluated employee performance and provided feedback.
Senior Clinical Research Coordinator
12.2020 - 11.2021
- Recruit, educate potential patients for and evaluate potential patient eligibility for clinical trials
- Assist clinical staff with study procedures, as outlined in the protocol and within state and institutional scope of practice
- Reviews and assists with editing of new protocols
- Assesses feasibility of research protocol including appropriate patient population, budget and specific needs for the study
Clinical Research Coordinator
University of Kansas Cancer Center
Westwood, KS
12.2018 - 12.2020
Research Assistant
University of Kansas Cancer Center
Westwood, KS
08.2017 - 12.2018
- Inform and consent patients to triple negative breast cancer and germline mutation registry
- Coordinate blood collection labs and associated tissue collection
- Write and edit clinical trial protocols, abstracts, and manuscripts.
Education
Biology, Health Science
University of Nebraska At Kearney
05.2017
Skills
- QUALIFICATIONS and SKILLS
- Knowledge of and ability to adhere to good clinical practices (GCP)
- Excellent organizational skills and attention to detail in maintaining accurate, retrievable records
- Strong analytical skills and ability to resolve technical or research problems and issues, and to interpret acceptability of data results
- Demonstrated ability to work independently with moderate direct supervision Excellent communication skills; oral and written Demonstrated ability to multitask Expert computer skills; medical terminology; investigative scientific methods
- Early and Late Phase Oncology protocol and informed consent development and implementation
Publications
· LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates,” Zur, A.A.; Chien, H.-C.; Augustyn, E.; Flint, A.; Heeren, N.; Finke, K.; Hernandez, C.; Hansen, L.; Miller, S.; Lin, L.; Giacomini, K.M.; Colas, C.; Schlessinger, A.; Thomas, A.A., Bioorg. Med. Chem. Lett. 2016, 26, 5000-5006.
· LAT-1 Activity of meta-Substituted Phenylalanine and Tyrosine Analogs” Augustyn, E.; Finke, K.; Zur, A.A.; Hansen, L; Heeren, N.; Chien, H.-C.; Lin, L.; Giacomini, K.M.; Colas, C.; Schlessinger, A.; Thomas, A.A., Bioorg. Med. Chem. Lett. 2016, 26, 2616-2621.
· Zur AA, Chien HC, Augustyn E, Flint A, Heeren N, Finke K, Hernandez C, Hansen L, Miller S, Lin L, Giacomini KM, Colas C, Schlessinger A, Thomas AA. “LAT1 activity of carboxylic acid bioisosteres: Evaluation of hydroxamic acids as substrates,” Bioorg. Med. Chem. Lett. 2016, 26, 5000-5006.
· Shah R, Wang YY, Finke K, Yoder R, O’Dea A, Nye LE, Sheshadri M, Hoffmann MS, Elia M, Crane GJ, Klemp JR, Khan QJ, Kimler BF, Sharma P. Comparison of outcomes for AJCC 8th anatomic and prognostic staging in contemporary triple negative breast cancer (TNBC) multisite registry [abstract]. J Clin Oncol. 2018;36(15 Suppl):abstr 555.
· Sharma P, Abramson VG, O’Dea A, Pathak HB, Pessetto ZY, Wang YY, Finke K, Hoffmann MS, Elia M, Lewis S, Scott J, De Jong J, Urban J, Heldstab J, Lafaver S, Williamson SK, Reed G, Kimler BF, Khan QJ, Godwin AK. Clinical and biomarker results from phase I/II study of PI3K inhibitor BYL 719 (alpelisib) plus nab-paclitaxel in HER2-negative metastatic breast cancer [abstract]. J Clin Oncol. 2018;36(15 Suppl):abstr 1018.
· Larson K, Wang Y, Finke K, … Sharma P. Impact of germline BRCA mutation status on survival in women with metastatic triple negative breast cancer. J Cancer Treat Res. 2019;7(4):81-86.
· Sharma P, Kimler B…Finke K…Khan Q. Randomized phase II trial of anthracycline-free and anthracycline-containing neoadjuvant carboplatin chemotherapy regimens in stage I-III triple-negative breast cancer (NeoSTOP). CCR-20-3646R1 pending publication.
· Sharma P, Kimler B,…Finke K…et al. Randomized phase II trial of anthracycline-free and anthracycline-containing neoadjuvant carboplatin chemotherapy regimens in stage I-III triple-negative breast cancer (NeoSTOP). Clin Cancer Res. 2021;27(4):975-982.
Timeline
Clinical Operations Manager
University of Kansas Cancer Center
11.2021 - Current
Senior Clinical Research Coordinator
12.2020 - 11.2021
Clinical Research Coordinator
University of Kansas Cancer Center
12.2018 - 12.2020
Research Assistant
University of Kansas Cancer Center
08.2017 - 12.2018
Biology, Health Science
University of Nebraska At Kearney